Red Meat & Cholesterol: Separating Fact from Fiction | Dr Kevin Maki
The Dr. Gabrielle Lyon Show
Advancements in Obesity Management Medications
This chapter explores the effectiveness of GLP-1 receptor agonists, particularly semaglutide and terzepatide, in managing obesity and their positive impacts on cardiovascular health and inflammation. It highlights the need for further research into these medications as tools for sustainable weight management, including their long-term benefits and potential risks. The discussion compares these therapies to bariatric surgery and stresses the importance of understanding their role in a comprehensive approach to obesity and health.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
